Eloxx Pharmaceuticals, Inc.
Price data unavailable
Track ELOX in your trading journalAbout Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. (ELOX) is a publicly listed company on US equity markets.
ELOXX PHARMACEUTICALS INC
The company reports trailing twelve-month revenue of $0 and net loss of $3.75M.
Key metrics include a return on equity of 49.5%, a debt-to-equity ratio of -2.26.
Use FINOTAUR to track ELOX's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $0 |
| Net Income (TTM) | $-3.75M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 49.50% |
| Debt-to-Equity | -2.26 |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·Jan 2
Global Mucopolysaccharidosis Treatment Market to Witness Robust Growth, Projected to Reach USD 5,014.5 Million by 2035 Growing at a CAGR of 5.9% | FMI
- GlobeNewswire Inc.·Dec 19
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight
- Investing.com·Jul 16
Eloxx Pharmaceuticals secures $3.2 million in additional funding - Investing.com
Want real-time analysis on ELOX?
Track it free in your trading journal. Log trades, tag setups, and review your edge.